Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Michael J. Abrams currently holds 42,097 shares of Arbutus Biopharma Corp (ABUS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Michael J. Abrams has been a net neutral trader of ABUS stock. They have purchased $0 and sold $0 worth of shares.
Michael J. Abrams's most recent insider trade was on Aug 16, 2016, when they sold 14,178 shares at $0.35 per share.
Michael J. Abrams serves as Executive at Arbutus Biopharma Corp (ABUS). They have executed 2 insider transactions totaling $0 over their tenure at the company.
Michael J. Abrams holds the position of Executive at Arbutus Biopharma Corp, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 11 years and currently hold a stake valued at $0.
Michael J. Abrams has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Michael J. Abrams was on Sep 11, 2015, when they sold $7.5K worth of TKMR shares. This transaction involved 17,044 shares at $0.44 per share.
Michael J. Abrams currently owns 42,097 shares of Arbutus Biopharma Corp (ABUS), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Michael J. Abrams's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Michael J. Abrams has 2 Form 4 filings on record as an insider at Arbutus Biopharma Corp.
Set alerts for Michael J. Abrams and 40,000+ other insiders.